on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Host Investor Webcast on November 17, 2025
Jaguar Health, Inc. has announced an investor webcast scheduled for Monday, November 17, 2025, at 8:30 a.m. Eastern Time. The webcast will address Jaguar's third-quarter 2025 financial performance and offer corporate updates. The announcement follows the company's plan to file its Earnings Report on November 14, 2025, concerning the quarter that ended on September 30, 2025.
Jaguar Health specializes in developing proprietary, plant-based prescription medicines targeting gastrointestinal issues. The company's family includes Napo Pharmaceuticals, focusing on supportive care for neglected gastrointestinal symptoms, and Napo Therapeutics, which aims to increase access to crofelemer in Europe. Additionally, Jaguar's efforts include a joint venture with Magdalena Biosciences targeting plant-derived mental health treatments.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news